Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Prosthetic-joint infection

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Septic prosthetic-joint infection requires emergency drainage

Biofilm around an implant resists host defence and antibiotics, while an acute infected arthroplasty can produce shock, wound failure and rapid tissue destruction; indiscriminate antibiotics in a stable patient can obscure the organism needed for definitive reconstruction.

Action: For sepsis, obtain urgent blood cultures, start parenteral protocol antibiotics and arrange experienced emergency drainage as soon as safe and within six hours when acutely unwell; for a stable patient, withhold antibiotics, obtain consultant review within 48 hours and secure synovial plus multiple deep tissue samples before antimicrobial treatment.

Synopsis

Recognise acute and indolent infection around joint replacement, separate septic instability from stable diagnostic sampling, protect deep-culture yield, classify evidence coherently, and select DAIR, staged exchange or salvage through a specialist implant-infection team.

  • Classify the clinical syndrome before prescribing: acute postoperative, acute haematogenous, chronic indolent and septic presentations have different sampling and surgical opportunities.
  • In sepsis, take blood cultures urgently and start parenteral protocol antibiotics, then drain emergently; current BOASt targets surgery within six hours for an acutely unwell patient when safe.
  • Do not give antibiotics to a stable patient until diagnostic synovial or deep tissue samples are obtained, unless a documented competing infection requires treatment.
  • Record index arthroplasty date, wound healing, later procedures, recent bacteraemia or infection, antibiotics, implant function and a cardiovascular assessment for endocarditis.
  • Initial tests include FBC, CRP, renal function and plain radiographs, but normal inflammatory markers do not exclude PJI, particularly with immunosuppression or low-virulence organisms.
  • A sinus communicating with the implant or visible prosthesis is confirmatory evidence; aspiration and tissue cultures are interpreted through EBJIS criteria rather than one cutoff alone.
  • At indicated debridement, obtain five deep microbiology specimens with separate sterile instruments and no-touch technique; take two histology specimens when chronic infection or diagnostic doubt exists.
  • DAIR is most useful for early or short-duration acute infection with stable components and viable soft tissue; exchange strategies address mature biofilm, loosening, poor tissue or unsuitable organisms.

Key red flags

Hypotension, confusion, lactate elevation, purulent drainage, rapidly spreading erythema or acute severe prosthetic-joint pain with bacteraemia requires immediate sepsis, orthopaedic and anaesthetic escalation.

A communicating sinus, visible prosthesis or persistent wound drainage is highly concerning and should not be repeatedly swabbed, probed or treated with short empirical oral courses.

Sudden joint pain during Staphylococcus aureus bacteraemia, skin infection or another septic focus suggests acute haematogenous seeding even years after uncomplicated implantation.

Normal CRP, white count or plain radiographs do not exclude low-grade infection, especially during immunosuppression or infection caused by low-virulence organisms.

Investigation priorities

01
First-line FBC, CRP and renal functionFirst stepFirst line

Measure systemic inflammation, sepsis severity and treatment safety.

02
First-line plain radiographsFirst line

Assess component position, loosening, osteolysis, fracture and baseline bone stock.

Management branches

SepticCulture, treat and drain emergently

Suspected PJI accompanies sepsis, organ dysfunction or rapidly progressive local infection.

  1. Start the sepsis pathway, obtain urgent blood cultures and inform orthopaedics, anaesthesia and microbiology immediately.
  2. Give local parenteral protocol antibiotics after blood cultures and do not wait for planned aspiration in an unstable patient.
  3. Perform experienced emergency drainage as soon as safe and within six hours when acutely unwell unless a documented reason prevents it.
  4. Take five deep cultures at debridement and search for endocarditis and other metastatic or primary infection sources.
StablePreserve the organism and define evidence

Pain, loosening or drainage suggests PJI without current sepsis.

  1. Withhold antibiotics, document index surgery, wound course, recent infection and agents and arrange consultant review within 48 hours.
  2. Obtain FBC, CRP, renal function, radiographs and image-guided synovial fluid with cultures, cell differential and crystals.
  3. Apply EBJIS evidence, treating a communicating sinus or exposed implant as confirmed and resolving discordance in the infection MDT.
  4. Plan five deep cultures and two histology samples at indicated surgery before any definitive organism-directed regimen.

Key medicines

Empiric parenteral therapy for septic PJIAfter urgent blood cultures, give the current hospital's full adult sepsis and PJI protocol doses immediately; obtain deep samples at emergency drainage and narrow promptly to organism, susceptibilities, source-control operation and renal function.Stable patients should not receive empirical therapy before synovial or deep sampling; allergy, renal injury, prior resistance and recent agents alter choice, and duration is not interchangeable between DAIR, exchange and suppressive strategies.
Rifampicin-containing biofilm therapy when selectedUse only the infection specialist's organism-confirmed combination regimen after adequate debridement and when the wound is controlled; never use rifampicin alone, and prescribe the exact partner, dose, duration and monitoring in writing.Potent enzyme induction reduces exposure to warfarin, direct oral anticoagulants, hormonal contraception and many other drugs; check liver function, resistance risk, pregnancy and all interactions before the first dose.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BOASt - Acute Management of Peri-Prosthetic Joint Infection
  • The EBJIS definition of periprosthetic joint infection
  • NICE NG125 Surgical site infections: prevention and treatment
  • NICE NG253 - Managing suspected sepsis
  • NICE BNF Rifampicin monograph

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom